HTR3B
5-hydroxytryptamine receptor 3B
Also known as: 5-HT3B, 5HT3B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95264
- Gene
- HTR3B
- Ensembl
- ENSG00000149305
- Chromosome
- 11
- Canonical length
- 441 aa
- Protein class
- FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The product of this gene belongs to the ligand-gated ion channel receptor superfamily. This gene encodes subunit B of the type 3 receptor for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor causes fast, depolarizing responses in neurons after activation. It is not functional as a homomeric complex, but a pentaheteromeric complex with subunit A (HTR3A) displays the full functional features of this receptor. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
441 residues, UniProt reviewed canonical sequence.
>O95264|HTR3B
1 MLSSVMAPLW ACILVAAGIL ATDTHHPQDS ALYHLSKQLL QKYHKEVRPV YNWTKATTVY
61 LDLFVHAILD VDAENQILKT SVWYQEVWND EFLSWNSSMF DEIREISLPL SAIWAPDIII
121 NEFVDIERYP DLPYVYVNSS GTIENYKPIQ VVSACSLETY AFPFDVQNCS LTFKSILHTV
181 EDVDLAFLRS PEDIQHDKKA FLNDSEWELL SVSSTYSILQ SSAGGFAQIQ FNVVMRRHPL
241 VYVVSLLIPS IFLMLVDLGS FYLPPNCRAR IVFKTSVLVG YTVFRVNMSN QVPRSVGSTP
301 LIGHFFTICM AFLVLSLAKS IVLVKFLHDE QRGGQEQPFL CLRGDTDADR PRVEPRAQRA
361 VVTESSLYGE HLAQPGTLKE VWSQLQSISN YLQTQDQTDQ QEAEWLVLLS RFDRLLFQSY
421 LFMLGIYTIT LCSLWALWGG VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HTR3B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 3.9 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 3.9 nTPM
- esophagus: 0.5 nTPM
- amygdala: 0.4 nTPM
- bone marrow: 0.4 nTPM
- testis: 0.4 nTPM
- hippocampal formation: 0.3 nTPM
Single-cell type
- renal collecting duct intercalated cells: 10 nCPM
- esophageal apical cells: 9.2 nCPM
- brain excitatory neurons: 3.2 nCPM
- platelets: 2.8 nCPM
- sertoli cells: 2.2 nCPM
- epididymal clear cells: 2 nCPM
Immune cell
- basophil: 1 nTPM
- neutrophil: 0.9 nTPM
- NK-cell: 0.4 nTPM
- naive B-cell: 0.3 nTPM
- plasmacytoid DC: 0.3 nTPM
- classical monocyte: 0.2 nTPM
Brain region
- cerebral cortex: 13 nTPM
- white matter: 7.9 nTPM
- basal ganglia: 7.4 nTPM
- amygdala: 5.4 nTPM
- cerebellum: 5.2 nTPM
- choroid plexus: 5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.03
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chemical synaptic transmission
- inorganic cation transmembrane transport
- monoatomic ion transmembrane transport
- regulation of membrane potential
- serotonin receptor signaling pathway
- serotonin-gated cation-selective signaling pathway
Molecular functions
- excitatory extracellular ligand-gated monoatomic ion channel activity
- serotonin-gated monoatomic cation channel activity
- transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Neurotransmitter-gated ion-channel transmembrane domain
- Neurotransmitter-gated ion-channel
- Neurotransmitter-gated ion-channel ligand-binding domain
- 5-hydroxytryptamine 3 receptor
- Neurotransmitter-gated ion-channel transmembrane domain superfamily
- Neurotransmitter-gated ion-channel ligand-binding domain superfamily
- Neuronal acetylcholine receptor
- 5-hydroxytryptamine 3 receptor, transmembrane domain
- Neurotransmitter-gated ion-channel ligand binding domain
- Neurotransmitter-gated ion-channel transmembrane region
- 5-hydroxytryptamine 3 receptor, B subunit
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HTR3B as an antibody target. Whether an autoantibody or antibody against HTR3B could matter depends on whether native HTR3B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HTR3B is annotated at the cell surface, where native HTR3B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HTR3B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...